收藏切换
Identification of novel anti-tuberculosis lead compound targeting shikimate kinase
收藏切换
PDF
Xia WANG, Ning-yu ZHU, Wei JIANG*, Shu-yi SI*
Acta Pharmaceutica Sinica | 2018, 53(6) : 878 - 886
Less
收藏切换
Acta Pharmaceutica Sinica | 2018, 53(6): 878-886
SPECIAL REPORTS
Identification of novel anti-tuberculosis lead compound targeting shikimate kinase
Full
Xia WANG, Ning-yu ZHU, Wei JIANG*, Shu-yi SI*
Affiliations
  • National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2018-06-12 doi: 10.16438/j.0513-4870.2018-0284
Outline
收藏切换

Shikimate kinase is a key protein of the shikimic pathway, which is essential for the survival of Mycobacterium tuberculosis. In this study, a screening assay for Mycobacterium tuberculosis shikimate ki-nase (MtSK) inhibitor was developed. A 120 000-compound library was screened by the enzyme assay and the phenotype screening using Mycobacterium smegmatis. A hit compound named IMB-T5297[(E)-3-(3-(3-chloro-5-methoxy-4-(prop-2-yn-1-yloxy)phenyl)acryloyl)-6-methyl-2H-pyran-2, 4(3H)-dione] was identified to be a selective inhibitor of MtSK with a half maximal inhibitory concentration (IC50) value of 1.745 μg·mL-1, which also showed antibacterial activity. The interaction between compound and protein was analyzed by surface plasmon resonance (SPR) experiment, which showed the KD value was 2.151×10-5 mol·L-1. The binding model of MtSK and compound was simulated by the computer program. Five key amino acids in the binding pocket were indispensable site-directed mutated to verify the model. IMB-T5297 inhibited Mycobacterium tuberculosis H37Rv with a minimum inhibitory concentration (MIC) value of 49.723 μg·mL-1 and displayed low cytotoxicity to mammalian cells. In this study, IMB-T5297 was identified as a selective inhibitor of MtSK enzyme with anti-tuberculosis activity. With additional structural modification, the compound has a potential to become a novel anti-tuberculosis compound.

Mycobacterium tuberculosis  /  shikimate kinase  /  drug screening  /  anti-tuberculosis drug
Xia WANG, Ning-yu ZHU, Wei JIANG, Shu-yi SI. Identification of novel anti-tuberculosis lead compound targeting shikimate kinase[J]. Acta Pharmaceutica Sinica, 2018 , 53 (6) : 878 -886 . DOI: 10.16438/j.0513-4870.2018-0284
Year 2018 volume 53 Issue 6
PDF
87
31
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2018-0284
  • Receive Date:2018-03-31
  • Online Date:2026-01-15
  • Published:2018-06-12
Article Data
Affiliations
History
  • Received:2018-03-31
  • Revised:2018-05-04
Funding
Affiliations
    National Laboratory for Screening New Microbial Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2018-0284
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT